LabCorp, Unilabs to enhance companion diagnostics
05 June 2018 | News
The partners will expand the network of laboratories that help biopharmaceutical organisations in developing and commercialising these diagnostics.
Image credit- clpmag.com
Life sciences firm LabCorp has entered a strategic collaboration with clinical laboratory testing services company Unilabs to enhance development and delivery of companion diagnostics globally for improving precision medicine.
The partners will expand the network of laboratories that help biopharmaceutical organisations in developing and commercialising these diagnostics.
In addition, commercialisation access will be enhanced in North America and Europe, with focus on diagnostics developed as well as validated by LabCorp and its drug development unit Covance.
The companies also intend to simplify technical, regulatory and clinical complications related to the assays using globally harmonised processes, which will initially be applied for oncology.
